Dasatinib induces autophagic cell death in human ovarian cancer.

Cancer
Xiao-Feng LeRobert C Bast

Abstract

Dasatinib, an inhibitor of Src/Abl family kinases, can inhibit tumor growth of several solid tumors. However, the effect and mechanism of action of dasatinib in human ovarian cancer cells remains unknown. Dasatinib-induced autophagy was determined by acridine orange staining, punctate localization of GFP-LC3, LC3 protein blotting, and electron microscopy. Significance of beclin 1, AKT, and Bcl-2 in dasatinib-induced autophagy and growth inhibition was assayed by small interfering RNA (siRNA) silencing and/or overexpression of the gene of interest. Dasatinib inhibited cell growth by inducing little apoptosis, but substantial autophagy in SKOv3 and HEY ovarian cancer cells. In vivo studies showed dasatinib inhibited tumor growth and induced both autophagy and apoptosis in a HEY xenograft model. Knockdown of beclin 1 and Atg12 expression with their respective siRNAs diminished dasatinib-induced autophagy, whereas knockdown of p27Kip1 with specific siRNAs did not. Small hairpin RNA knockdown of beclin 1 expression reduced dasatinib-induced autophagy and growth inhibition. Dasatinib reduced the phosphorylation of AKT, mTOR, p70S6K, and S6 kinase expression. Constitutive expression of AKT1 and AKT2 inhibited dasatinib-induced autopha...Continue Reading

References

Oct 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J E SmartJ M Bishop
Dec 2, 2000·Science·D J Klionsky, S D Emr
Aug 10, 2001·The Journal of Biological Chemistry·H HuangD J Tindall
Jan 7, 2004·Journal of Neurosurgery·Takao KanzawaIsabelle M Germano
Jun 2, 2005·Nature Reviews. Molecular Cell Biology·Julian J LumCraig B Thompson
Sep 24, 2005·Cell·Sophie PattingreBeth Levine
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Faye M JohnsonNicholas J Donato
Mar 17, 2006·Cancer Research·Sophie Pattingre, Beth Levine
Jul 29, 2006·Autophagy·Eeva-Liisa Eskelinen
Jan 27, 2007·Cell·Isabel ChuJoyce Slingerland
Jan 15, 2008·Cell·Beth Levine, Guido Kroemer
May 24, 2008·Autophagy·Beth LevineGuido Kroemer
Aug 19, 2008·Biochimica Et Biophysica Acta·Eeva-Liisa Eskelinen, Paul Saftig
Oct 1, 2008·Journal of Translational Medicine·Alex J EustaceNorma O'Donovan
Oct 10, 2008·Molecular Biology of the Cell·Eisuke ItakuraNoboru Mizushima
Dec 17, 2008·Cell Death and Differentiation·B Levine, G Kroemer
Dec 17, 2008·Cell Death and Differentiation·N Kourtis, N Tavernarakis
Feb 5, 2009·Molecular Cancer Therapeutics·Vanessa MilanoJohn de Groot
Jun 16, 2009·Cell·Robin MathewEileen White
Oct 29, 2009·British Journal of Cancer·G E KonecnyD J Slamon
Jul 1, 2008·Autophagy·Beth LevineGuido Kroemer

❮ Previous
Next ❯

Citations

Apr 9, 2013·Acta Pharmacologica Sinica·Xin LiJin-ku Bao
Aug 3, 2010·Nature Reviews. Cancer·Nicola McCarthy
Aug 5, 2011·Journal of the National Cancer Institute·Xiao-Feng LeRobert C Bast
Aug 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fiona SimpkinsJoyce M Slingerland
Dec 12, 2012·Genes & Cancer·Sourik S Ganguly, Rina Plattner
Oct 20, 2012·Endocrine-related Cancer·Justin S GundaraStan B Sidhu
Nov 13, 2012·Future Neurology·Zhao Zhong ChongKenneth Maiese
Jan 11, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Angeles Alvarez SecordSusan K Murphy
May 16, 2015·Molecular Medicine Reports·Juan XiaoJundong Li
Jun 29, 2011·The American Journal of the Medical Sciences·Yumin LiWenting He
Dec 26, 2012·Trends in Molecular Medicine·Kenneth MaieseShaohui Wang
Sep 18, 2012·Progress in Neurobiology·Zhao Zhong ChongKenneth Maiese
Oct 15, 2013·International Journal of Cancer. Journal International Du Cancer·T OrfanelliS S Witkin
Apr 18, 2016·Drug Discovery Today·Zhao Zhong Chong
Aug 29, 2012·Expert Opinion on Therapeutic Targets·Kenneth MaieseShaohui Wang
Aug 20, 2014·BioMed Research International·Guido ValenteCiro Isidoro
Jul 25, 2012·Cancer Biology & Therapy·Hidemi Rikiishi
Jun 8, 2011·Cancer Biology & Therapy·Xiao-Feng Le, Robert C Bast
Oct 22, 2014·Immunology and Cell Biology·Donna DentonSharad Kumar
Jan 9, 2016·Critical Reviews in Clinical Laboratory Sciences·Subhadip MukhopadhyaySujit Kumar Bhutia
Jan 1, 2012·Cells·Priyank KumarZhe-Sheng Chen
Nov 9, 2016·Oncotarget·Lei ZhanBing Wei
May 30, 2012·Oncology Reports·Hiroshi ShigetomiHiroshi Kobayashi
Jul 1, 2016·Molecular Medicine Reports·Ying PanBing Su
Feb 14, 2013·International Journal of Oncology·Yumin LiXiangting Zeng
Mar 13, 2018·Frontiers in Physiology·Joanne J A van BavelMarcel A G van der Heyden
Sep 30, 2015·Oncotarget·Joe R DelaneyDwayne G Stupack
Feb 16, 2018·Journal of Pharmacokinetics and Pharmacodynamics·Tanaya VaidyaSihem Ait-Oudhia
Dec 6, 2018·BMC Complementary and Alternative Medicine·Daohua ShiHuajiao Chen
Sep 19, 2018·Cancer Chemotherapy and Pharmacology·Lei ZhanBing Wei
Jul 2, 2016·Molecular Cancer Therapeutics·Rowan E MillerAlan Ashworth

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis